5-Phenyl-1,3-oxazole-4-carboxylic acid → 5-Phenyl-oxazole-4-carboxylic acid [1-(3-acetyl-benzyl)-1H-pyrazol-4-yl]-amide
Reaktionsgleichung
[CH3:1][C:2]1([C:7]2[CH:8]=[C:9]([CH:17]=[CH:18][CH:19]=2)[CH2:10][N:11]2[CH:15]=[C:14]([NH2:16])[CH:13]=[N:12]2)[O:6]CCO1.[C:20]1([C:26]2[O:30][CH:29]=[N:28][C:27]=2[C:31](O)=[O:32])[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=1>>[C:2]([C:7]1[CH:8]=[C:9]([CH:17]=[CH:18][CH:19]=1)[CH2:10][N:11]1[CH:15]=[C:14]([NH:16][C:31]([C:27]2[N:28]=[CH:29][O:30][C:26]=2[C:20]2[CH:21]=[CH:22][CH:23]=[CH:24][CH:25]=2)=[O:32])[CH:13]=[N:12]1)(=[O:6])[CH3:1]Komponenten
3
Versuchsvorschrift
Following general procedure B followed by C, starting from 1-[3-(2-methyl-[1,3]dioxolan-2-yl)-benzyl]-1H-pyrazol-4-ylamine and 5-phenyl-oxazole-4-carboxylic acid. LC-MS-conditions 02: tR=1.00 min; [M+H]+=387.06.
Quellen und Nachweise
- ORD-Eintrag
- ord-c3f9187aa8b04259bc5137dbfd582869
- Quelldatensatz
- uspto-grants-2012_10
- DOI